RA PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
RA PHARMACEUTICALS, INC. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $41.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-05-11
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $41.00K.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-12-31 was $96.25M, a 27637.46% increase year-over-year.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2015-12-31 was $347.00K.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $125.24M, a 331.43% increase from fiscal 2015.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $29.03M, a 235.82% increase from fiscal 2014.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $8.64M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | $41.00K 10-Q · filed 2017-05-11 | $96.29M derived: sum of 2 quarters · filed 2017-05-11 | ||
| 2016-12-31 | $96.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $125.24M 10-K · filed 2017-03-06 | ||
| 2016-09-30 | $28.99M 10-Q · filed 2016-11-29 | |||
| 2015-12-31 | $347.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $29.03M 10-K · filed 2017-03-06 | ||
| 2015-09-30 | $28.68M 10-Q · filed 2016-11-29 | |||
| 2014-12-31 | $8.64M 10-K · filed 2017-03-06 |